跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 181 条关于
“Altaris”
全部
181
临床试验
96
药物
17
机构
31
资讯
37
去年
MSD Acquires WuXi Biologics' Irish Vaccine Facility for $500M Amid Regulatory Pressures
去年
Minaris Advanced Therapies Launches as Global Cell Therapy CDMO Powerhouse
去年
Kalaris and AlloVir Complete Merger to Advance Novel Anti-VEGF Therapy for Retinal Diseases
去年
Allovir and Kalaris Therapeutics Merge to Focus on Retinal Disease Therapies
16天前
Altria Sues FDA to Overhaul Tobacco Product Review System
2年前
Aclaris Therapeutics Initiates Phase IIa Trial of ATI-2138 for Atopic Dermatitis
去年
Probiotic Supplementation Alters Gut Microbiota in Peritoneal Dialysis Patients
8个月前
Aptar's Nasal Delivery Technology Advances CastleVax Phase II COVID-19 Vaccine Trial
去年
Aptar's N-Sorb Nitrosamine Mitigation Solution Accepted into FDA's Emerging Technology Program
去年
Syndax's Revuforj Approved for Leukemia, Biosion Inks $940M Antibody Deal with Aclaris
第 1 页,共 4 页
上一页
下一页